Amadix
VerifiedAmadix is a biopharmaceutical company specialised in cancer diagnosis. Its products address unmet medical needs in oncology, such as colorectal cancer and advanced adenoma diagnosis in blood. Learn more
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$5—8m (Dealroom.co estimates Mar 2020.)
Company register number B47665294
Valladolid Castile and León (HQ)
Deals in current and previous year:
- hard tech
- biotechnology
- sustainable development goals
- horizon europe
- woman founder
- testing
- developer tools
- eit ecosystem
- oncology
- predictive analytics
- eit health
- eit supernovas
- eicfund
- investor network (eit health)
- biopsy
- investor network 2020 (eit health)
- digital sandbox (eit health)
- digital sandbox 2020 (eit health)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | $0.0 | round |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor investor | $0.0 | round | |
| investor | $0.0 | round | |
N/A | Early VC | ||
| Total Funding | 000k | ||
Related Content
Recent News about Amadix
EditMore about Amadix
EditDeveloper of medical technologies designed to detect tumours years in advance, before the symptoms appear. The company's technologies are oriented towards non-invasive early cancer detection, avoiding the complications of existing invasive procedures, as tumour biopsies, enabling doctors to provide suitable treatment to the patient.
Keywords: Pharmaceuticals and Biotechnology, Artificial Inteligence, Cancer Detection, Cancer Diagnostic System, Diagnostic Tools, Disruptive Diagnostic Technology, Oncology Diagnostic Test, Tumor Detection.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Amadix
Edit
ACQUISITION by Amadix Feb 2013